COMMUNIQUÉS West-GlobeNewswire

Incyclix Bio Granted U.S. FDA Fast Track Designation for INX-315 to Treat CCNE1-Amplified Platinum-Resistant/Refractory Ovarian Cancer

29/04/2025 - 14:00

Fast Track designation highlights potential of INX-315 to address unmet need for patients with recurrent advanced/metastatic cancer RESEARCH TRIANGLE PARK, N.C., April 29, 2025 (GLOBE NEWSWIRE) -- Incyclix Bio, LLC, a [...]

Breaking new ground in mental health research: Oxford University, Boehringer Ingelheim, and Cumulus Neuroscience launch first of its kind study investigating the day-to-day experience of patients with psychiatric disorders

29/04/2025 - 14:00

Ingelheim, Germany, Oxford and Belfast, UK, April 29, 202 5   – Boehringer Ingelheim, the University of Oxford , and Cumulus Neuroscience are joining forces to provide insights into the day-to-day experiences of people [...]

Statement re Grant of Options and Warrants

29/04/2025 - 08:00

DXS INTERNATIONAL PLC (AQSE: DXSP) Granting of Share Options and Warrants The Board of DXS International plc (the “Company” or “DXSP), the AQSE Growth Market quoted clinical decision support developer and supplier of [...]

deepull secures oversubscribed €50 million Series C financing to advance UllCORE diagnostic system for direct-from-blood rapid pathogen detection

29/04/2025 - 09:30

deepull secures oversubscribed €50 million Series C financing to advance UllCORE diagnostic system for direct-from-blood rapid pathogen detection Round co-led by Columbus Venture Partners, Panakès Partners and Mérieux [...]

DEBRA Research Announces Impact Investment into Nova Anchora to Advance Protein Therapy for Epidermolysis Bullosa

29/04/2025 - 10:00

Additional investors include global investment firm Viking Global Investors, charity foundation CureEB, the Epidermolysis Bullosa Medical Research Foundation (EBMRF), and Stanford University. The financing will enable [...]

L’entreprise de biotechnologie britannique Stablepharma Ltd. lance en première mondiale un essai de Phase I ciblé sur un vaccin thermostable contre le tétanos et la diphtérie

29/04/2025 - 10:36

LONDRES, 29 avr. 2025 (GLOBE NEWSWIRE) -- Après avoir obtenu l’autorisation de la MHRA, l’autorité britannique de réglementation du marché des dispositifs médicaux, Stablepharma Ltd. entre en essai clinique de Phase I [...]

Lumineye Introduces Sublingual Nano-Drop Formula to Help Support Normal Eye Comfort and Clarity

29/04/2025 - 06:18

Sheridan, Wyoming, USA, April 29, 2025 (GLOBE NEWSWIRE) -- Lumineye , a pioneering company in the health and wellness sector, today announced the launch of its new product: The Lumineye Nanodrop. This advanced dietary [...]

Roche granted FDA Breakthrough Device Designation for first AI-driven companion diagnostic for non-small cell lung cancer

29/04/2025 - 07:00

The VENTANA TROP2 (EPR20043) RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment. The device uses artificial intelligence-based image analysis [...]

Santhera Full Year Results for the Year Ended 31 December 2024

29/04/2025 - 07:00

Transformational year following the successful launch of AGAMREE® Pratteln, Switzerland, April 29, 2025 – Santhera Pharmaceuticals (SIX: SANN) today announces its full year results for the year ended 31 December 2024. [...]

Novartis continues strong momentum with double-digit sales growth, robust margin expansion and multiple approvals in Q1

29/04/2025 - 07:00

Ad hoc announcement pursuant to Art. 53 LR Net sales grew +15% (cc 1 , +12% USD) with core operating income 1 up +27% (cc, +23% USD) Sales growth driven by continued strong performance from Entresto (+22% cc), Kisqali [...]

New data with daridorexant assessing the transition from night to day in insomnia disorder published in Sleep Medicine

29/04/2025 - 07:00

Daridorexant improved sleep maintenance throughout the entire night, including the last quarter, while also improving next-morning sleepiness. Daridorexant improved next-morning sleepiness compared to placebo from as [...]

Santhera Publishes Agenda for its Annual General Meeting

29/04/2025 - 07:00

Pratteln, Switzerland, April 29, 2025 – Santhera Pharmaceuticals (SIX: SANN) today published the invitation to its Annual General Meeting (AGM), which will be held on May 20, 2025, at 10:00 CEST at Haus der Wirtschaft, [...]

Vivoryon Therapeutics N.V. Reports Full Year 2024 Financial Results and Provides Business Update

29/04/2025 - 07:00

Vivoryon Therapeutics N.V. Reports Full Year 2024 Financial Results and Provides Business Update Successful strategic shift towards a focus on inflammatory and fibrotic diseases, in particular on kidney disease [...]

Le Conseil d'Administration de la Financière de Tubize nomme Bruno Holthof comme Président

29/04/2025 - 08:00

Le Conseil d'Administration de la Financière de Tubize nomme Bruno Holthof comme Président Suite à la décision de Gaëtan Hannecart de ne pas solliciter le renouvellement de son mandat d'administrateur lors de l' [...]

The Board of Directors of Financière de Tubize appoints Bruno Holthof as new Chair

29/04/2025 - 08:00

The Board of Directors of Financière de Tubize appoints Bruno Holthof as new Chair As Gaëtan Hannecart did not seek renewal of his director’s mandate at the general shareholders meeting held on April 25, 2025, the Board [...]

Solésence To Report First Quarter 2025 Financial Results and Host a Conference Call

28/04/2025 - 22:01

ROMEOVILLE, Ill., April 28, 2025 (GLOBE NEWSWIRE) -- Romeoville, Ill., April 28, 2025 – Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, [...]

Spero Therapeutics Appoints Esther Rajavelu as President and Chief Executive Officer

28/04/2025 - 22:01

CAMBRIDGE, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics , Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and [...]

Bicara Therapeutics Highlights Broad Potential of Ficerafusp Alfa at AACR Annual Meeting 2025

28/04/2025 - 22:01

BOSTON, April 28, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, [...]

Kane Biotech Announces Fourth Quarter and Full Year 2024 Financial Results, Narrows Strategic Focus and Makes Leadership Change

28/04/2025 - 22:05

WINNIPEG, Manitoba, April 28, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) today announced its fourth quarter and full year 2024 financial results. Fourth [...]